The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/18980173

Download in:

View as

General Info

PMID
18980173